Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data

Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data

<strong>Background</strong> The clinical and epidemiological significance of HIV-associated Mycobacterium tuberculosis bloodstream infection (BSI) is incompletely understood. We hypothesised that M tuberculosis BSI prevalence has been underestimated, that it independently predicts death,...

Bibliografski detalji
Glavni autori:	Barr, DA, Lewis, JM, Feasey, N, Schutz, C, Kerkhoff, AD, Jacob, ST, Andrews, B, Kelly, P, Lakhi, S, Muchemwa, L, Bacha, HA, Hadad, DJ, Bedell, R, van Lettow, M, Zachariah, R, Crump, JA, Alland, D, Corbett, EL, Gopinath, K, Singh, S, Griesel, R, Maartens, G, Mendelson, M, Ward, AM, Parry, CM, Talbot, EA, Munseri, P, Dorman, SE, Martinson, N, Shah, M, Cain, K, Heilig, CM, Varma, JK, von Gottberg, A, Sacks, L, Wilson, D, Squire, SB, Lalloo, DG, Davies, G, Meintjes, G
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2020

Slični predmeti

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
od: Griesel, R, i dr.
Izdano: (2023)

Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial [version 1; peer review: 2 approved]
od: Rulan Griesel, i dr.
Izdano: (2021-01-01)

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
od: Keene, CM, i dr.
Izdano: (2023)

Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial
od: Zhao, Y, i dr.
Izdano: (2023)

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
od: Fiona Mendelson, i dr.
Izdano: (2018-08-01)

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
od: Tom H. Boyles, i dr.
Izdano: (2018-10-01)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
od: Keene, CM, i dr.
Izdano: (2021)

Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis
od: Rulan Griesel, i dr.
Izdano: (2018-02-01)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
od: Zhao, Y, i dr.
Izdano: (2021)

Guidelines for antiretroviral therapy in adults
od: G Meintjes, i dr.
Izdano: (2012-08-01)

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients
od: Gary Maartens, i dr.
Izdano: (2018-07-01)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
od: Ying Zhao, i dr.
Izdano: (2022-09-01)

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
od: Morroni C, i dr.
Izdano: (2006-07-01)

Clofazimine for the treatment of tuberculosis
od: Jacob A. M. Stadler, i dr.
Izdano: (2023-02-01)

Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection [version 2; peer review: 2 approved]
od: Rebecca Lester, i dr.
Izdano: (2020-06-01)

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
od: Helen van der Plas, i dr.
Izdano: (2013-01-01)

Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study
od: Wilson Douglas, i dr.
Izdano: (2008-05-01)

Diet–Microbiota Interactions Alter Mosquito Development
od: Vincent G. Martinson, i dr.
Izdano: (2021-06-01)

Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi.
od: Luke Mair, i dr.
Izdano: (2020-01-01)

The prevention and treatment of opportunistic infections in HIV-infected adults
od: G. Maartens
Izdano: (2003-12-01)

Tuberculosis preventive therapy in HIV infection
od: G. Maartens
Izdano: (2001-07-01)

The prevention and treatment of opportunistic infections in HIV-infected adults
od: G. Maartens
Izdano: (2002-07-01)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial [version 1; peer review: 2 approved, 1 approved with reservations]
od: Zimasa Gcwabe, i dr.
Izdano: (2021-02-01)

A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre [version 2; peer review: 2 approved, 1 approved with reservations]
od: Graeme Meintjes, i dr.
Izdano: (2022-05-01)

Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV--a case series.
od: Tom H Boyles, i dr.
Izdano: (2012-01-01)

Involving expert patients in antiretroviral treatment provision in a tertiary referral hospital HIV clinic in Malawi
od: Tenthani Lyson, i dr.
Izdano: (2012-06-01)

Why are people still dying of HIV in Africa?
od: G. Meintjes
Izdano: (2014-04-01)

Adult antiretroviral therapy guidelines 2014
od: G. Meintjes
Izdano: (2014-01-01)

Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi.
od: Megan Landes, i dr.
Izdano: (2012-01-01)

Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis
od: James E. Scriven, i dr.
Izdano: (2018-03-01)

Programme Improvement: Analysis of Internship Assessment of the Bachelors of Languages and Communication Degree at One University in Zimbabwe
od: Stella Muchemwa
Izdano: (2018-03-01)

University Quality Assurance in Zimbabwe: A Case of Solusi University
od: Stella Muchemwa
Izdano: (2017-09-01)

Grade Retention at Primary School: What the Teachers in Zimbabwe Say
od: Muchemwa Stella
Izdano: (2017-03-01)

English Teachers Preparedness in the Implementation of Performance Lag Address Programme (PLAP) at Secondary School Level in Zimbabwe
od: Muchemwa Stella
Izdano: (2018-06-01)

Characterization of exosomes in peritoneal fluid of endometriosis patients
od: Nazri, HM, i dr.
Izdano: (2020)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
od: Kairoonisha Mahomed, i dr.
Izdano: (2020-07-01)

Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE): protocol for a multisite prospective observational study of the causes of fever in Africa and Asia
od: Hopkins, H, i dr.
Izdano: (2020)

ROLE OF CHLORINE IN IMPROVING SELECTIVITY IN THE OXIDATIVE COUPLING OF METHANE TO ETHYLENE
od: Burch, R, i dr.
Izdano: (1989)

Comparative study of catalysts for the oxidative coupling of methane
od: Burch, R, i dr.
Izdano: (1988)

COMPARATIVE-STUDY OF CATALYSTS FOR THE OXIDATIVE COUPLING OF METHANE
od: Burch, R, i dr.
Izdano: (1988)